Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000403349

Medchemexpress LLC (-)-p-Bromotetramisole oxalate | 62284-79-1 | 99.8% | 373.22 | 5 MG
SDP

Catalog No. 5000403349
Encompass_Preferred

(-)-p-Bromotetramisole oxalate is an alkaline phosphatase inhibitor. It is applicable to research related to erythroleukemia. In vitro, (-)-p-Bromotetramisole oxalate (0.3-0.4 mM; 5 days) potently inhibits terminal cell division-associated MEL DS-19 cell differentiation induced by 0.7% DMSO or 1.2 mM HMBA, reducing B+ cell levels. It also potently inhibits purified human liver, bone, spleen, and kidney alkaline phosphatase isoenzymes (10^-5-10^-4 mol/liter; under assay conditions at 30 °C) while minimally inhibiting purified human intestinal and placental alkaline phosphatase isoenzymes.

  • Alkaline phosphatase inhibitor.
  • Applicable to research related to erythroleukemia.
  • Potently inhibits terminal cell division-associated MEL DS-19 cell differentiation.
  • Potently inhibits purified human liver, bone, spleen, and kidney alkaline phosphatase isoenzymes.

Catalog No. 50-004-03349 Supplier Medchemexpress LLC Supplier No. HY196955MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

(-)-p-Bromotetramisole oxalate is an alkaline phosphatase inhibitor. It is applicable to research related to erythroleukemia. In vitro, (-)-p-Bromotetramisole oxalate (0.3-0.4 mM; 5 days) potently inhibits terminal cell division-associated MEL DS-19 cell differentiation induced by 0.7% DMSO or 1.2 mM HMBA, reducing B+ cell levels. It also potently inhibits purified human liver, bone, spleen, and kidney alkaline phosphatase isoenzymes (10^-5-10^-4 mol/liter; under assay conditions at 30 °C) while minimally inhibiting purified human intestinal and placental alkaline phosphatase isoenzymes.

  • Alkaline phosphatase inhibitor.
  • Applicable to research related to erythroleukemia.
  • Potently inhibits terminal cell division-associated MEL DS-19 cell differentiation.
  • Potently inhibits purified human liver, bone, spleen, and kidney alkaline phosphatase isoenzymes.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.